Many faces of a cancer-supporting protein

John F. Darby and Paul Workman ()
Additional contact information
John F. Darby: John F. Darby and Paul Workman are in the Cancer Research UK Cancer Therapeutics Unit, Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, UK.
Paul Workman: John F. Darby and Paul Workman are in the Cancer Research UK Cancer Therapeutics Unit, Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, UK.

Nature, 2011, vol. 478, issue 7369, 334-335

Abstract: The protein Hsp90 is a target of promising anticancer drugs. An analysis of the components of Hsp90 complexes in tumours reveals a path that may lead to predictive assays of drug sensitivity in cancer patients.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/478334b Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:478:y:2011:i:7369:d:10.1038_478334b

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/478334b

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().